Brendan Chang retweetledi

@maximeronot reframed the debate on imaging for HCC surveillance:
▶️HCC surveillance is a public health strategy, not a diagnostic duel between tests
▶️Ultrasound remains the backbone of surveillance at population level
▶️Abbreviated MRI offers real advantages, but only for selected high risk patients or after inadequate ultrasound
▶️Risk stratification and ultrasound visualisation scores are central to choosing the right modality
▶️The future of surveillance must be evidence driven, with outcomes, costs and equity evaluated in parallel
💬 “The real question is not which test performs better, but which strategy delivers the most benefit to the largest number of patients.”
#LiverCancerSummit

English









